Home Approval of new antibiotic by Cubist to help in $100 trillion global fight
 

Keywords :   


Approval of new antibiotic by Cubist to help in $100 trillion global fight

2014-12-22 17:40:08| Biotech - Topix.net

Friday's FDA approval of the latest new antibiotic by Cubist Pharmaceuticals is a step toward combating a problem estimated to kill 10 million people and cost $100 trillion globally by 2050. Late Friday, U.S. regulators gave the nod to Zerbaxa, formerly known by the generic name of ceftolozane/tazobactam, for the treatment of adults with complicated urinary tract infections and complicated intra-abdominal infections caused by certain so-called Gram-negative bacteria, typically considered among the hardest to kill.

Tags: global fight approval antibiotic

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11Costume
24.11BB S604ULS
24.1133
24.11 ElectronicAudioExperimentsDude Incedible
24.11 TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »